Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 5586 (MIR5586) is a small, non-coding RNA molecule involved in the fine-tuning of gene expression in human cells. Like other miRNAs, MIR5586 is transcribed as a precursor that undergoes several processing steps, resulting in a mature ~22-nucleotide RNA. It regulates target mRNAs primarily by binding to complementary sequences in their 3' untranslated regions (UTRs), leading to translational repression or mRNA degradation. MIR5586 has gained interest as a diagnostic biomarker for classifying lymphoma subtypes, where miR-5586-5p expression can distinguish GCB-DLBCL from ABC-DLBCL. Its full spectrum of biological functions and disease involvement remains under investigation.
In principle, any miRNA-targeted therapy would use one or more of the following mechanisms: Antisense oligonucleotides (ASOs) to inhibit miRNA function; miRNA mimics to restore lost activity; Small molecules or exosome-based delivery altering miRNA-mRNA binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 5586 (MIR5586).